Immucell logo

Immucell share price today

(ICCC)

Immucell share price is $5.49 & ₹471.10 as on 7 Jan 2025, 2.30 'hrs' IST

$5.49

0.34

(6.5%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Immucell share price in Dollar and Rupees. Guide to invest in Immucell stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Immucell, along with analyst recommendations, forecasts, and comprehensive financials.

Immucell share price movements

  • Today's Low: $4.94
    Today's High: $5.49

    Day's Volatility :10.02%

  • 52 Weeks Low: $3.34
    52 Weeks High: $5.82

    52 Weeks Volatility :42.61%

Immucell Returns

PeriodImmucell CorpIndex (Russel 2000)
3 Months
40.71%
0.0%
6 Months
20.05%
0.0%
1 Year
7.52%
0.0%
3 Years
-39.41%
-19.8%

Immucell Key Statistics

in dollars & INR

Previous Close
$5.15
Open
$4.94
Today's High
$5.49
Today's Low
$4.94
Market Capitalization
$32.1M
Today's Volume
$2.0K
52 Week High
$5.82
52 Week Low
$3.34
Revenue TTM
$23.2M
EBITDA
$-633.7K
Earnings Per Share (EPS)
$-0.49
Profit Margin
-17.44%
Quarterly Earnings Growth YOY
-0.63%
Return On Equity TTM
-16.1%

How to invest in Immucell from India?

It is very easy for Indian residents to invest directly in Immucell from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Immucell stock in both Indian Rupees (INR) and US Dollars (USD). Search for Immucell or ICCC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Immucell or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Immucell shares which would translate to 0.156 fractional shares of Immucell as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Immucell, in just a few clicks!

Returns in Immucell for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immucell investment value today

Current value as on today

₹1,17,836

Returns

₹17,836

(+17.84%)

Returns from Immucell Stock

₹14,614 (+14.61%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Immucell

22%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Immucell on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 22% more investors are searching Immucell in the last 30 days versus the previous period.

Global Institutional Holdings in Immucell

  • Cresset Asset Management, LLC

    2.96%

  • Vanguard Group Inc

    2.53%

  • Renaissance Technologies Corp

    1.68%

  • Bleichroeder LP

    1.14%

  • Dimensional Fund Advisors, Inc.

    0.82%

  • Morgan Stanley - Brokerage Accounts

    0.71%

Analyst Recommendation on Immucell

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Immucell(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Immucell

What analysts predicted

Upside of 155.01%

Current:

$5.49

Target:

$14.00

Insights on Immucell

  • Price Movement

    In the last 3 months, ICCC stock has moved up by 41.1%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 5.47M → 6.01B (in $), with an average increase of 99.9% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -437.86K → -701.69M (in $), with an average decrease of 22981.6% per quarter
  • ICCC vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 15.9%
  • ICCC vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 97.7%
  • Price to Sales

    ForICCC every $1 of sales, investors are willing to pay $1.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Immucell Financials in INR & Dollars

FY18Y/Y Change
Revenue
$11.0M
↑ 5.32%
Net Income
$-2.3M
↑ 1282.14%
Net Profit Margin
-21.14%
↓ 19.53%
FY19Y/Y Change
Revenue
$13.7M
↑ 24.91%
Net Income
$-1.3M
↓ 44.19%
Net Profit Margin
-9.44%
↑ 11.7%
FY20Y/Y Change
Revenue
$15.3M
↑ 11.8%
Net Income
$-1.0M
↓ 21.14%
Net Profit Margin
-6.66%
↑ 2.78%
FY21Y/Y Change
Revenue
$19.2M
↑ 25.43%
Net Income
$-78.0K
↓ 92.37%
Net Profit Margin
-0.41%
↑ 6.25%
FY22Y/Y Change
Revenue
$18.6M
↓ 3.51%
Net Income
$-2.5M
↑ 3097.44%
Net Profit Margin
-13.43%
↓ 13.02%
FY23Y/Y Change
Revenue
$17.5M
↓ 5.9%
Net Income
$-5.8M
↑ 131.54%
Net Profit Margin
-33.05%
↓ 19.62%
Q2 FY23Q/Q Change
Revenue
$3.5M
↑ 2.5%
Net Income
$-1.4M
↓ 40.4%
Net Profit Margin
-39.06%
↑ 28.11%
Q3 FY23Q/Q Change
Revenue
$5.4M
↑ 52.76%
Net Income
$-940.0K
↓ 31.87%
Net Profit Margin
-17.42%
↑ 21.64%
Q4 FY23Q/Q Change
Revenue
$5.1M
↓ 5.57%
Net Income
$-1.1M
↑ 21.28%
Net Profit Margin
-22.37%
↓ 4.95%
Q1 FY24Q/Q Change
Revenue
$7.3M
↑ 42.42%
Net Income
$-437.9K
↓ 61.59%
Net Profit Margin
-6.03%
↑ 16.34%
Q2 FY24Q/Q Change
Revenue
$5.5M
↓ 24.59%
Net Income
$-1.5M
↑ 249.79%
Net Profit Margin
-27.99%
↓ 21.96%
Q3 FY24Q/Q Change
Revenue
$6.0B
↑ 109742.75%
Net Income
$-701.7M
↑ 45713.4%
Net Profit Margin
-11.67%
↑ 16.32%
FY18Y/Y Change
Profit
$5.2M
↓ 0.52%
FY19Y/Y Change
Profit
$6.7M
↑ 29.77%
FY20Y/Y Change
Profit
$6.9M
↑ 1.82%
FY21Y/Y Change
Profit
$8.7M
↑ 26.13%
FY22Y/Y Change
Profit
$7.6M
↓ 11.63%
FY23Y/Y Change
Profit
$4.4M
↓ 42.52%
Q2 FY23Q/Q Change
Profit
$1.0M
↑ 247.07%
Q3 FY23Q/Q Change
Profit
$1.3M
↑ 21.36%
Q4 FY23Q/Q Change
Profit
$1.3M
↓ 0.7%
Q1 FY24Q/Q Change
Profit
$2.3M
↑ 82.46%
Q2 FY24Q/Q Change
Profit
$1.2M
↓ 46.39%
Q3 FY24Q/Q Change
Profit
$1.6B
↑ 128593.38%
FY18Y/Y Change
Operating Cash Flow
$-373.4K
↓ 131.76%
Investing Cash Flow
$-1.8M
↓ 85.38%
Financing Cash Flow
$889.6K
↓ 90.87%
FY19Y/Y Change
Operating Cash Flow
$233.5K
↓ 162.54%
Investing Cash Flow
$-3.4M
↑ 89.71%
Financing Cash Flow
$6.9M
↑ 680.35%
FY20Y/Y Change
Operating Cash Flow
$1.3M
↑ 463.39%
Investing Cash Flow
$-2.6M
↓ 24.49%
Financing Cash Flow
$1.9M
↓ 72.47%
FY21Y/Y Change
Operating Cash Flow
$954.2K
↓ 27.47%
Investing Cash Flow
$-1.6M
↓ 37.84%
Financing Cash Flow
$3.9M
↑ 102.97%
FY22Y/Y Change
Operating Cash Flow
$-1.5M
↓ 261.8%
Investing Cash Flow
$-4.0B
↑ 248076.77%
Financing Cash Flow
$1.1M
↓ 71.27%
Q1 FY23Q/Q Change
Operating Cash Flow
$-2.8M
↑ 112.82%
Investing Cash Flow
$-682.2K
↓ 99.98%
Financing Cash Flow
$748.6K
↓ 401.61%
Q2 FY23Q/Q Change
Operating Cash Flow
$-681.4K
↓ 75.33%
Investing Cash Flow
$-708.4K
↑ 3.85%
Financing Cash Flow
$-251.9K
↓ 133.65%

Immucell Technicals Summary

Sell

Neutral

Buy

Immucell is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Immucell Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Immucell Corp
3.21%
20.05%
7.52%
-39.41%
1.78%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Immucell Corp
NA
NA
0.0
0.0
-0.16
-0.05
NA
3.23
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Immucell Corp
Buy
$32.1M
1.78%
NA
-17.44%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Immucell

immucell corporation is a biotechnology company based out of portland maine. immucell's focus is to create scientifically-proven and practical products that result in a measurable economical impact on animal health and productivity in the dairy and beed industries.
Organization
Immucell
Employees
75
CEO
Mr. Michael F. Brigham
Industry
Health Technology

Management People of Immucell

NameTitle
Mr. Michael F. Brigham
President, CEO, Principal Financial Officer, Treasurer, Secretary & Director
Ms. Bobbi Jo Brockmann
VP of Sales & Marketing and Director
Ms. Elizabeth L. Williams
Vice President of Manufacturing Operations
Ms. Elizabeth S. Toothaker
Director of Finance & Administration and Controller
Mr. A. Gustavo Scaffa
Senior Director of Quality
John W. Zinckgraf
Director of Product Development

Important FAQs about investing in Immucell from India :

What is Immucell share price today?

Immucell share price today stands at $5.49, Open: $4.94 ; Previous Close: $5.15 ; High: $5.49 ; Low: $4.94 ; 52 Week High: $5.82 ; 52 Week Low: $3.34. The stock opens at $4.94, after a previous close of $5.15. The stock reached a daily high of $5.49 and a low of $4.94, with a 52-week high of $5.82 and a 52-week low of $3.34.

Can Indians buy Immucell shares?

Yes, Indians can invest in the Immucell (ICCC) from India.

With INDmoney, you can buy Immucell at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Immucell at zero transaction cost.

How can I buy Immucell shares from India?

It is very easy to buy Immucell from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Immucell be purchased?

Yes, you can buy fractional shares of Immucell with INDmoney app.

What are the documents required to start investing in Immucell stocks?

To start investing in Immucell, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Immucell

Today’s highest price of Immucell (ICCC) is $5.49.

Today’s lowest price of Immucell (ICCC) is $4.94.

What is today's market capitalisation of Immucell

Today's market capitalisation of Immucell ICCC is 32.1M

What is the 52 Week High and Low Range of Immucell

  • 52 Week High

    $5.82

  • 52 Week Low

    $3.34

What are the historical returns of Immucell?

  • 1 Month Returns

    3.21%

  • 3 Months Returns

    20.05%

  • 1 Year Returns

    7.52%

  • 5 Years Returns

    1.78%

Who is the Chief Executive Officer (CEO) of Immucell

Mr. Michael F. Brigham is the current Chief Executive Officer (CEO) of Immucell.